Increased Detection of Lymphatic Vessel Invasion by D2-40 (Podoplanin) in Early Breast Cancer: Possible Influence on Patient Selection for Accelerated Partial Breast Irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 1128-1133

  Debald, Manuel ^a   Pölcher, Martin ^a   Flucke, Uta ^a   Walgenbach Brünagel, Gisela ^a   Walgenbach, Klaus Jürgen ^a   Höller, Tobias ^a   Wolfgarten, Matthias ^a   Rudlowski, Christian ^a   Büttner, Reinhard ^a   Schild, Hans ^a   Kuhn, Walther ^a   Braun, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

accelerated partial breast irradiation; Breast cancer; D2 40; LVI; lymphatic vessel invasion

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; AXILLARY NODES; BREAST CANCER; BREAST RADIOTHERAPY; BREAST TUMOR; CLINICAL MANAGEMENT; DATA SUPPORT; DETECTION RATES; DUCTAL ADENOCARCINOMAS; EARLY BREAST CANCER; EARLY-STAGE BREAST CANCER; IMMUNOSTAINING; INFORMATION CONCERNING; LYMPHATIC VESSELS;

RADIOTHERAPY; TUMORS;

IRRADIATION;

MONOCLONAL ANTIBODY D2-40; PODOPLANIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CONTROLLED STUDY; EARLY CANCER; FALSE POSITIVE RESULT; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH VESSEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SELECTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; WHOLE-BODY IRRADIATION;

EID: 77953610863     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.088     Document Type: Article

References (39)

1. Cuzick J., Stewart H., Peto R., et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 71 (1987) 7-14
2. Harris J.R. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys 35 (1996) 641-648
3. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
4. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
5. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
6. Fisher E.R., Anderson S., Tan-Chiu E., et al. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 91 (2001) 1679-1687
7. Sanders M.E., Scroggins T., Ampil F.L., et al. Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 25 (2007) 996-1002
8. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
9. Offersen B.V., Overgaard M., Kroman N., et al. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review. Radiother Oncol 90 (2009) 1-13
10. Sauer R., Sautter-Bihl M.L., Budach W., et al. Accelerated partial breast irradiation: Consensus statement of 3 German Oncology societies. Cancer 110 (2007) 1187-1194
11. Polgar C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-Year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 694-702
12. Coombs N.J., and Boyages J. Multifocal and multicentric breast cancer: Does each focus matter?. J Clin Oncol 23 (2005) 7497-7502
13. Yerushalmi R., Kennecke H., Woods R., et al. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 117 (2009) 365-370
14. Egan R.L. Multicentric breast carcinomas: Clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 49 (1982) 1123-1130
15. Arthur D.W., Vicini F.A., Kuske R.R., et al. Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society. Brachytherapy 2 (2003) 124-130
16. American Society of Breast Surgeons. Consensus Statement for Accelerated Partial Breast Irradiation. Available from: www.breastsurgeons.org/officialstmts/APBI_statement_revised_100708.pdf. Accessed February, 15. 2009.
17. Ott O.J., Hildebrandt G., Potter R., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 82 (2007) 281-286
18. Pepper M.S., Tille J.C., Nisato R., et al. Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314 (2003) 167-177
19. Rosen P.P., Groshen S., Saigo P.E., et al. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: A study of 644 patients with median follow-up of 18 years. J Clin Oncol 7 (1989) 1239-1251
20. Shoup M., Malinzak L., Weisenberger J., et al. Predictors of axillary lymph node metastasis in T1 breast carcinoma. Am Surg 65 (1999) 748-752
21. Chua B., Ung O., Taylor R., et al. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg 71 (2001) 723-728
22. Lauria R., Perrone F., Carlomagno C., et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 76 (1995) 1772-1778
23. Van den Eynden G.G., Van der Auwera I., Van Laere S.J., et al. Distinguishing blood and lymph vessel invasion in breast cancer: A prospective immunohistochemical study. Br J Cancer 94 (2006) 1643-1649
24. Schacht V., Dadras S.S., Johnson L.A., et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166 (2005) 913-921
25. Kahn H.J., and Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82 (2002) 1255-1257
26. Ito M., Moriya T., Ishida T., et al. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer. Breast Cancer 14 (2007) 381-387
27. Braun M., Flucke U., Debald M., et al. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): A clinically useful predictor for axillary lymph node metastases. Breast Cancer Res Treat 112 (2008) 503-511
28. Harper J.L., Jenrette J.M., Vanek K.N., et al. Acute complications of MammoSite brachytherapy: A single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 61 (2005) 169-174
29. Krishnan L., Jewell W.R., Tawfik O.W., et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7 (2001) 91-96
30. Remmele W., and Stegner H.E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8 (1987) 138-140
31. Goldhirsch A., Glick J.H., Gelber R.D., et al. Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16 (2005) 1569-1583
32. Buchholz T.A. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med 360 (2009) 63-70
33. Athas W.F., Adams-Cameron M., Hunt W.C., et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92 (2000) 269-271
34. Kuerer H.M., Julian T.B., Strom E.A., et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 239 (2004) 338-351
35. Arthur D.W., and Vicini F.A. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 23 (2005) 1726-1735
36. Bartelink H. Intraoperative radiotherapy for breast cancer: Tail wagging the dog?. Lancet Oncol 5 (2004) 207-208
37. Arnaout-Alkarain A., Kahn H.J., Narod S.A., et al. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 20 (2007) 183-191
38. Marinho V.F., Metze K., Sanches F.S., et al. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer 8 (2008) 64
39. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106